Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 115, Issue 4, 2001, Pages 854-861

  Jelinek, Diane F ^a,b   Tschumper, Renee C ^a   Geyer, Susan M ^a   Bone, Nancy D ^a   Dewald, Gordon W ^a   Hanson, Curtis A ^a   Stenson, Mary J ^a   Witzig, Thomas E ^a   Tefferi, Ayalew ^a   Kay, Neil E ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

CD38; Chronic lymphocytic leukaemia; Germline; Immunoglobulin; Somatic mutation

Indexed keywords

CD38 ANTIGEN; IMMUNOGLOBULIN;

ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; GENE SEQUENCE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; SOMATIC MUTATION; SURVIVAL;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; B-LYMPHOCYTES; BIOLOGICAL MARKERS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; GENES, IMMUNOGLOBULIN; GENETIC MARKERS; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MEMBRANE GLYCOPROTEINS; NAD+ NUCLEOSIDASE; PROPORTIONAL HAZARDS MODELS; RISK; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 0035679122     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.03149.x     Document Type: Article

References (26)

1. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
2. Updated data on V gene mutation status and CD38 expression in B-CLL
3. Human CD38 (ADP. -ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member
4. + lymphocytes. Role of the human CD38 molecule
5. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors
6. Chronic lymphocytic leukemia: New insights into biology and therapy
7. Immunophenotypic characterization of acute leukemias and chronic lymphoproliferative disorders: Practical recommendations and classifications
8. H genes are associated with a more aggressive form of chronic lymphocytic leukemia
9. Immunoglobulin V genes and CD38 expression in CLL (correspondence)
10. Nonparametric estimation for incomplete observations
11. Somatic hypermutation in normal and transformed human B cells
12. Ligation of CD38 suppresses human B lymphopoiesis
13. Enzymatic functions and structures of CD38 and homologs
14. Phase II, study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia
15. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression
16. VH, gene expression in CD5 positive and CD5 negative B cell chronic lymphoid malignancies
17. H genes is a detrimental prognostic factor in chronic lymphocytic leukemia (correspondence)
18. H gene mutation in B-cell chronic lymphocytic leukemia (correspondence)
19. Apoptosis in B-chronic lymphocytic leukaemia
20. Lack of allelic exclusion in B cell chronic lymphocytic leukemia
21. Molecular biology of chronic lymphocytic leukemia
22. Chronic lymphocytic leukemia
23. A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia
24. H and gene mutational status and prognosis in chronic lymphocytic leukemia (correspondence)
25. CD, 38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells
26. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis